The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

Yilmaz, M; Karakoc, A; Toruner, FB; Cakir, N; Tiras, M.BÜLENT; Ayvaz, G; Arslan, M

doi:10.1080/09513590500231627

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

Yilmaz M., Karakoc A., Toruner F., Cakir N., Tiras B., Ayvaz G., ...More

GYNECOLOGICAL ENDOCRINOLOGY, vol.21, no.3, pp.154-160, 2005 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 21 Issue: 3
Publication Date: 2005
Doi Number: 10.1080/09513590500231627
Journal Name: GYNECOLOGICAL ENDOCRINOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.154-160
Keywords: polycystic ovary syndrome, menstrual cyclicity, hirsutism, metformin, rosiglitazone, INSULIN-RESISTANCE, CLOMIPHENE CITRATE, OBESE WOMEN, DOUBLE-BLIND, INDUCED OVULATION, THERAPY IMPROVES, HORMONE-BINDING, HYPERANDROGENISM, ENDOCRINE, GROWTH
Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Objective. The aim of the present study was to assess the effects of metformin and rosiglitazone on menstrual cyclicity and hirsutism in patients with polycystic ovary syndrome (PCOS).